Tirzepatide, marketed as Zepbound for weight management, has shown higher average weight loss than semaglutide in many trial comparisons
Studies such as the LEADER trial (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have shown reductions in major adverse cardiovascular events, including heart attack and stroke, in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk
Why the tea amino acid wins Read the full review NewBrain Energy & Nootropics 11 July 2026 Dihexa vs Methylene Blue for Brain Fog & Cognitive Energy: The 2026 UK Review Methylene blue or Dihexa for brain fog
When interpreting the tests results, it is important to keep in mind that both lactulose and mannitol are metabolized by the colonic microbiota, thus cannot be used in ulcerative colitis or irritable bowel syndrome, which mostly affect the colon
In addition to quieting that food noise, these types of weight loss medications can actually reduce heart disease, "that might be independent of weight loss," in addition to "improvements in heart function and functional status in individuals with heart failure." The medication is also currently being studied for how it can target symptoms of kidney disease and Alzheimer's
